Home › Funds › SUPERSTRING CAPITAL MANAGEMENT LP › ORIC
SUPERSTRING CAPITAL MANAGEMENT LP position in ORIC
ORIC PHARMACEUTICALS INC · Health Care
SUPERSTRING CAPITAL MANAGEMENT LP reported holding 406,077 shares of ORIC (ORIC PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$4.4M, representing 2.78% of its reported portfolio and ranking #15 among its reported holdings. SUPERSTRING CAPITAL MANAGEMENT LP has disclosed ORIC holdings in 8 of the last 8 reported quarters, going back to Q3 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How SUPERSTRING CAPITAL MANAGEMENT LP's ORIC position evolved
SUPERSTRING CAPITAL MANAGEMENT LP first disclosed a stake in ORIC in Q3 2024 at 949,522 shares (US$9.7M). Across 8 filings, SUPERSTRING CAPITAL MANAGEMENT LP increased the stake 3 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 406,077 shares valued at US$4.4M — an increase of 290,843 shares quarter over quarter.. Notable position changes include a 310% increase in Q1 2025 (shares rose 82% over the following quarter), a 186% increase in Q4 2025 (shares rose 55% over the following quarter), a 252% increase in Q2 2026 (shares rose 24% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 949.52K | $9.73M | New |
| Q4 2024 | 200.00K | $1.61M | Reduce |
| Q1 2025 | 819.19K | $4.57M | Add |
| Q2 2025 | 344.92K | $3.50M | Reduce |
| Q3 2025 | 89.35K | $1.07M | Reduce |
| Q4 2025 | 255.37K | $2.09M | Add |
| Q1 2026 | 115.23K | $1.46M | Reduce |
| Q2 2026 | 406.08K | $4.40M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ORIC and 13F data
ORIC (ORIC PHARMACEUTICALS INC) is a Health Care company. 41 other funds we track also report a position in ORIC — the largest reported positions include Nextech Invest Ltd. (US$77.6M), EcoR1 Capital, LLC (US$72.9M), SR ONE CAPITAL MANAGEMENT, LP (US$50.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ORIC
- Nextech Invest Ltd. 7.16M sh · $77.57M · Q2 2026
- EcoR1 Capital, LLC 6.73M sh · $72.87M · Q2 2026
- SR ONE CAPITAL MANAGEMENT, LP 4.62M sh · $49.98M · Q2 2026
- Venrock Adviser, LLC 4.32M sh · $46.78M · Q2 2026
- NEA Management Company, LLC 4.12M sh · $44.60M · Q2 2026
- AIHC Capital Management Ltd 3.83M sh · $41.46M · Q2 2026
- Column Group LLC 3.54M sh · $38.35M · Q2 2026
- Siren, L.L.C. 3.00M sh · $32.47M · Q2 2026
- First Turn Management, LLC 2.02M sh · $21.85M · Q2 2026
- Integral Health Asset Management, LLC 1.90M sh · $20.58M · Q2 2026
- MPM BioImpact LLC 1.88M sh · $20.38M · Q2 2026
- Vivo Capital, LLC 1.85M sh · $20.02M · Q2 2026
More on SUPERSTRING CAPITAL MANAGEMENT LP
FAQ
How long has SUPERSTRING CAPITAL MANAGEMENT LP held ORIC?
SUPERSTRING CAPITAL MANAGEMENT LP has disclosed ORIC holdings in 8 of the last 8 reported quarters, going back to Q3 2024.
What is SUPERSTRING CAPITAL MANAGEMENT LP's current position in ORIC?
As of Q2 2026, SUPERSTRING CAPITAL MANAGEMENT LP holds 406.08K shares of ORIC (ORIC PHARMACEUTICALS INC), valued at $4.40M, representing 2.78% of its reported portfolio and ranking #15.
Has SUPERSTRING CAPITAL MANAGEMENT LP been buying or selling ORIC?
In the latest 13F filing (Q2 2026), SUPERSTRING CAPITAL MANAGEMENT LP increased its position in ORIC.
Which other funds hold ORIC?
Other major institutional holders of ORIC include Nextech Invest Ltd., EcoR1 Capital, LLC, SR ONE CAPITAL MANAGEMENT, LP, among 41 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.